California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on September 2, 2026

Sep. 2, 2026

Beauty Education Enters a New Era With Anastasia Andreani

Indeterminate EIN Presswire

Sep. 2, 2026

Parsa Mohebi Hair Restoration Launches Controlled Human Study of Verteporfin in Hair Transplant Donor Healing

Indeterminate EIN Presswire

Sep. 2, 2026

Del Rae Behavioral Health Hosts Open House for San Diego Healthcare Professionals and Community Partners

Indeterminate EIN Presswire

Sep. 2, 2026

Patients Travel to Los Angeles for Brain Vascular Malformation Surgery from a Surgeon Who Has Treated Over 1,200

Indeterminate EIN Presswire

Sep. 2, 2026

Tummy Tuck and Liposuction FAQs: El Dorado Hills Plastic Surgeon Answers Common Questions

Indeterminate EIN Presswire

Sep. 2, 2026

7 Digit Dental Marketing DSO SEO Services Help Dental Support Organizations Dominate Local Search and Acquire Patients

Indeterminate EIN Presswire

Sep. 2, 2026

Alta Centers Now In-Network with Curative Health Insurance

Indeterminate EIN Presswire

Sep. 2, 2026

Fuel50 Founders Outline a New Vision for Workforce Intelligence in the Age of AI

Indeterminate EIN Presswire

Sep. 2, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 août 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

Sep. 2, 2026

BioRestorative Therapies Announces Reverse Stock Split

Indeterminate GlobeNewswire

Sep. 2, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 2, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 2, 2026

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 2, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 2, 2026

Supernus Pharmaceuticals to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Vireo Growth Announces Conference Attendance for September 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean

Indeterminate GlobeNewswire

Sep. 2, 2026

SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company

Indeterminate GlobeNewswire